About
Non-coding RNA based therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
406
By Phase
PHASE4: 1PHASE2: 2PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06722586Collaborator
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
PHASE4Recruiting
84 participants
Started: Jan 7, 2025 · Completed: Dec 31, 2027
NCT05953831Lead Sponsor
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
PHASE2Withdrawn
Started: Apr 30, 2024 · Completed: Sep 30, 2025
NCT05350969Lead Sponsor
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
PHASE2Completed
294 participants
Started: Jul 7, 2022 · Completed: Mar 17, 2025
NCT04045405Lead Sponsor
Clinical Study to Assess Safety, PK and PD Parameters of CDR132L
PHASE1Completed
28 participants
Started: Jun 21, 2019 · Completed: Jun 26, 2020
Locations (1)
Headquarters
Hanover, Germany
Map
Loading map...